Synergistic anticancer activity of arsenic trioxide with erlotinib is based on inhibition of EGFR-mediated DNA double-strand break repair (Q42712120)
Jump to navigation
Jump to search
scientific article published on 2 April 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Synergistic anticancer activity of arsenic trioxide with erlotinib is based on inhibition of EGFR-mediated DNA double-strand break repair |
scientific article published on 2 April 2013 |
Statements
1 reference
Synergistic anticancer activity of arsenic trioxide with erlotinib is based on inhibition of EGFR-mediated DNA double-strand break repair (English)
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Siegfried Knasmüller
1 reference
Mir Alireza Hoda
1 reference
Franziska Ferk
1 reference
Claudia Karnthaler-Benbakka
1 reference
2 April 2013
1 reference
1 reference
Identifiers
1 reference